Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis
about
Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-AnalysisImaging biomarker roadmap for cancer studiesMaximum standardized uptake value on FDG-PET predicts survival in stage I non-small cell lung cancer following carbon ion radiotherapy.Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer.Clinical outcomes of CyberKnife stereotactic radiosurgery for elderly patients with presumed primary stage I lung cancer.The impact of intratumoral metabolic heterogeneity on postoperative recurrence and survival in resectable esophageal squamous cell carcinoma.Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy.Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy.Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (18 F-FDG-PET) in the treatment of bone metastases: results from a 3-arm randomized phase II trial.Present and future roles of FDG-PET/CT imaging in the management of lung cancer.Prognositc significance of SUVmax on pretreatment 18 F-FDG PET/CT in early-stage non-small cell lung cancer treated with stereotactic body radiotherapy: A meta-analysis.Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.Meta-analysis of prognostic studies for a biomarker with a study-specific cutoff value.Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.Watch the weathercock: changes in re-staging 18F-FDG PET/CT scan predict the probability of relapse in locally advanced non-small cell lung cancer.CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy.Time-dependent summary receiver operating characteristics for meta-analysis of prognostic studies.Repeatability of FDG PET/CT metrics assessed in free breathing and deep inspiration breath hold in lung cancer patients.Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy.
P2860
Q26771327-7110DA22-0403-447B-9281-881FD475E472Q30242020-76A1D70D-9A84-4F5E-805E-B66F077E8FCEQ33750851-5DCC7A77-8898-41EF-B9DC-E1150EB06E5CQ35131272-5DBF4A0B-366D-458D-AB4D-66B75B539835Q36993625-55E5C5EF-9334-4D5C-B420-3DE5815CD8B2Q37241935-77E6E482-5FE4-4CA4-B401-B554B10B75D9Q37691881-B568FC6D-AF57-495E-820B-B9834BA9AE92Q37716473-628A9EA9-8E4D-488A-A373-12859BC043E0Q38377300-8F87C3C1-E45C-4676-AEED-0C2B762A677BQ38401313-485EEBDA-4E31-4656-A878-632DD0053BD1Q38406129-821C0F3C-A976-4EF6-A2B3-5B31C3B0C3C2Q38819166-6E0BD935-2988-4F1B-A9E7-77AC9C2A3251Q38925620-BBBA6E34-FBBC-412E-A307-23A1BC61F221Q39135164-7ED7A647-C15A-4F1D-A930-067DC89D370FQ40000127-442C979B-2781-476D-AC3D-75DD5D89859FQ40967181-62E9E771-714B-46DE-882E-C5AD08EAE768Q41555630-DA6C234F-FABB-40FC-AD2E-31ABEF5619BBQ42363929-59DDF62A-50F1-4D98-81AB-9715B235A537Q48369218-5123E764-42F8-4850-A054-880A27D461A4Q49666975-C1FDD83C-7253-48B9-B093-5EBCC0E7696BQ51736041-54497C74-9E89-4198-A6EC-87647BA43EFDQ53064016-4A192354-0C99-4F6D-9F51-2CACCFAD81FFQ54966312-597646D3-2099-4EAE-B167-66D717526C1EQ55119541-F7F7562D-0268-4263-B3DA-D2379720049C
P2860
Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Primary tumor standardized upt ...... ng radiotherapy: meta-analysis
@ast
Primary tumor standardized upt ...... ng radiotherapy: meta-analysis
@en
Primary tumor standardized upt ...... ng radiotherapy: meta-analysis
@nl
type
label
Primary tumor standardized upt ...... ng radiotherapy: meta-analysis
@ast
Primary tumor standardized upt ...... ng radiotherapy: meta-analysis
@en
Primary tumor standardized upt ...... ng radiotherapy: meta-analysis
@nl
prefLabel
Primary tumor standardized upt ...... ng radiotherapy: meta-analysis
@ast
Primary tumor standardized upt ...... ng radiotherapy: meta-analysis
@en
Primary tumor standardized upt ...... ng radiotherapy: meta-analysis
@nl
P2093
P2860
P31
P921
P3181
P1476
Primary tumor standardized upt ...... ng radiotherapy: meta-analysis
@en
P2093
P2860
P304
P3181
P356
10.1097/JTO.0000000000000185
P407
P50
P577
2014-06-01T00:00:00Z